Skip to the card

2026-11-01 issue

Observed arrival · 2026-11-01

Peptide Chooser puts the evidence next to the hype

peptidechooser.com Visit website
Editorial interest 83/100 Selection signal · not a rating of the site

A goal-by-goal comparison of peptide claims and approved alternatives, with FDA status, prices, evidence limits, and links to sellers or providers.

Landing page captured for the 2026-11-01 issue.
For
People comparing peptide claims with approved options
Worth noticing
The hair-loss section says it does not link to injectable peptides sold by research-use shops because they are unapproved for any use.

Field notes

The page groups options by goal and separates approved drugs from cosmetics and unapproved products, while showing descriptions, evidence limitations, approval labels, and prices where available. Its hair-loss section says injectable peptides sold for hair have no human evidence for that use and are not approved for any use. The site says some links pay it, links to its rating method and sources, and notes that the full comparison for this goal is not yet published.

Observed signals

Read the marks

Editorial observations of this landing page, not a rating.

○OpenPublic substance visible
$PaidCommerce or pricing visible
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use

One card from the complete issue

Somebody Else’s Snowbank

294,871 arrived 1,000 judged 977 catalogued Enter the complete issue
peptidechooser.com

Landing page observed 2026-11-01. The live site may have changed.